Q32 Bio Corp (QTTB): Total Asset Value of Company
The market capitalization trend for Q32 Bio Inc. (QTTB) on the GURU.Markets platform is currently at 91.00. The business relies on strict temperature control during the transportation of therapies for patients with autoimmune diseases. The development of unique antibodies and lobbyist support create a defensive barrier against competitors under FDA oversight. Demand for selective agents is rising as the biologics market is still in its formative stages.
Comprehensive metric breakdowns and analytics for q32bio.com (QTTB)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Fundamental valuation:QTTB, Q32 Bio Corp
Investors assess the risk of capital loss through the dynamics of the resource base, which in biotech companies lacking revenue and pricing power depends exclusively on external financing. By analyzing changes in balance sheet assets calculated reversely via ROA, one can determine the funding available for clinical development at Q32 Bio Inc. (QTTB), where a stable trend indicates the maintenance of operational viability until FDA drug approval.
Competitors of Q32 Bio Inc. (QTTB)
ARGX (argenx.com) - Aggregate Company Assets|Aggregate Company Assets BioNTech BNTX|Total Asset Value of Company Abivax|ADMA Bio (ADMA) - Company Total Assets|Aggregate Asset Value Protagonist Corp (PTGX)|Company Total Assets IMVT (Immunovant, Inc.)|kiniksa.com - Company Total Assets|Aggregate Company Assets Grifols (GRFS)|ADPT: Aggregate Asset Value|CLDX (Celldex) - Aggregate Company Assets|Aurinia Corp (AUPH) - Cumulative Company Assets|BCRX (BioCryst) - Company Total Assets|Company Total Assets veratx.com (VERA)|Dianthus Therapeutics, Inc. (DNTH) - Cumulative Company Assets|Aggregate Asset Value Pharvaris NV (PHVS)|Company Total Assets ABCL|Tourmaline - Company Total Asset Base|PGEN: Aggregate Company Assets|PHAR: Cumulative Company Assets|NKTR (Nektar Therapeutics Inc.) - Aggregate Company Assets|Cumulative Company Assets Upstream Bio, Inc.|ZBIO (Zenas Biopharma, Inc.) - Cumulative Company Assets|Company Total Assets IMNM|Aggregate Company Assets Gossamer Bio, Inc. GOSS|Total Business Assets kalvista.com (KALV)|SEPN: Company Total Assets|Pieris Pharma - Company Assets|Aggregate Company Assets SVRA|Rigel Corp (RIGL) - Company Balance Sheet Assets|AnaptysBio, Inc. (ANAB) - Cumulative Company Assets|Aggregate Company Assets astriatx.com|ENGN - Cumulative Company Assets|Aggregate Asset Value RAPT Therapeutics Inc.|Company Total Assets Aerovate Therapeutics Inc (JBIO)|Aggregate Company Assets Aclaris Therapeutics, Inc (ACRS)|Company Total Assets KYTX|tizianalifesciences.com - Company Total Asset Base|CABA (Cabaletta Bio) - Aggregate Company Assets|Ventyx Biosciences Inc. (VTYX) - Company Assets|Cumulative Company Assets Theratechnologies Inc THTX|Avalo Therapeutics Inc (AVTX) - Aggregate Asset Value|ELDN: Company Total Assets|Company Total Asset Base AGEN|Aggregate Company Assets Climb Bio CLYM|Total Business Assets Zura Bio Ltd (ZURA)|aTyr - Company Total Assets|ADAG - Cumulative Company Assets|Cumulative Company Assets IMA (Ikena Oncology, Inc.)|STTK: Company Total Asset Base|Aggregate Company Assets EQ (equilliumbio.com)|Company Balance Sheet Assets Connect Biopharma Holdings Limited|Immunic Therapeutics (IMUX) - Cumulative Company Assets|Aggregate Business Assets Atara Biotherapeutics Inc (ATRA)|Cumulative Company Assets InflaRx N.V.|Aggregate Business Assets x4pharma.com (XFOR)|Company Total Assets Adicet Bio, Inc. ACET|Celularity Inc - Aggregate Company Assets|Aggregate Company Assets INmune Bio Corp|BRNS - Total Asset Value of Company|Company Total Assets Kezar Life Sciences KZR|sabbiotherapeutics.com (SABS) - Aggregate Asset Value|AKTX (Akari Therapeutics Plc) - Company Total Assets|Company Total Assets ENLV|GeoVax Labs Inc (GOVX) - Aggregate Company Assets|Aggregate Asset Value EDSA (Edesa Biotech Corp)|iBio, Inc. - Aggregate Company Assets|Cumulative Company Assets Carisma Therapeutics Inc CARM|XTL Biopharmaceuticals Ltd. - Company Total Assets|Bolt Biotherapeutics (BOLT) - Company Total Assets|Cumulative Company Assets hcwbiologics.com HCWB|Aptevo Therapeutics Inc. (APVO) - Aggregate Asset Value|AIM: Company Total Assets|Company Total Asset Base ADTX|Aggregate Company Assets GRI (GRI Bio)|Cumulative Company Assets XRTX (XORTX Therapeutics Inc)|ReShape Lifesciences - Aggregate Company Assets|REVB - Cumulative Company Assets|Indaptus Therapeutics - Cumulative Company Assets|SCNI: Company Total Assets|Aggregate Company Assets calcimedica.com|Affimed N.V. (AFMD) - Total Business Assets|Company Total Assets ALLK (Allakos Inc)|Company Assets HOOK|IGMS: Aggregate Company Assets|Company Balance Sheet Assets iteostherapeutics.com ITOS|Cumulative Company Assets Ocean Biomedical OCEA|TCBP - Aggregate Company Assets|Cumulative Company Assets Third Harmonic Bio, Inc (THRD)